Company / Tangible Book Value per Share
Bristol Myers Squibb Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$1.58
FY2025
5-year range
-$2.51 / $8.99
FY2021-FY2025
Trend
+37.1%
vs FY2024
Sector context
#194 of 209
Health Care
What the data says
Among 209 Health Care companies, Bristol Myers Squibb is in the bottom 7% for tangible book value per share. Tangible Book Value per Share returned to growth in FY2025 after 5 years of decline, reaching $-1.58.
Based on SEC 10-K filings.
-1.58 in FY2025.
Declined from $3.69 to $-1.58 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 209This company -$1.58 Sector average $93.47
▼
-101.7% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 37.1% year-over-year.
- Ranks #194 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
- Lowest tangible book value per share in the period was in FY2024.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.58 | +37.1% |
| FY2024 | -$2.51 | -168.0% |
| FY2023 | $3.69 | -21.1% |
| FY2022 | $4.68 | -48.0% |
| FY2021 | $8.99 | -14.8% |
| FY2020 | $10.55 | -40.1% |
| FY2019 | $17.62 | +295.1% |
| FY2018 | $4.46 | +53.5% |
| FY2017 | $2.91 | -47.8% |
| FY2016 | $5.57 | +25.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026